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Oral-facial-digital type 1 syndrome (OFD1 [MIM 311200]) is transmitted as an X-linked dominant condition with
lethality in males and is characterized by malformations of the face, oral cavity, and digits, and by a highly variable
expressivity even within the same family. Malformation of the brain and polycystic kidneys are commonly associated
with this disorder. The locus for OFD1 was mapped by linkage analysis to a 12-Mb interval, flanked by markers
DXS85 and DXS7105 in the Xp22 region. To identify the gene responsible for this syndrome, we analyzed several
transcripts mapping to the region and found mutations in OFD1 (formerly named “Cxorf5/71-7a”), encoding a
protein containing coiled-coil a-helical domains. Seven patients with OFD1, including three with familial and four
with sporadic cases, were analyzed. Analysis of the familial cases revealed a missense mutation, a 19-bp deletion,
and a single base-pair deletion leading to a frameshift. In the sporadic cases, we found a missense (de novo), a
nonsense, a splice, and a frameshift mutation. RNA in situ studies on mouse embryo tissue sections show that
Ofd1 is developmentally regulated and is expressed in all tissues affected in OFD1 syndrome. The involvement of
OFD1 in oral-facial-digital type I syndrome demonstrates an important role of this gene in human development.
Introduction
Oral-facial-digital syndromes (OFDS) are a heteroge-
neous group of developmental disorders of which at least
nine different forms have been described (Toriello 1993).
Oral-facial-digital type 1 (OFD1 [MIM 311200]) syn-
drome was first reported in 1954 by Papillon-League
and Psaume (1954) and was further defined in 1962 by
Gorlin and Psaume (1962). This syndrome is transmitted
as an X-linked dominant condition with lethality in
males (Doege et al. 1964; Wettke-Schafer and Kantner
1983) and is characterized by malformations of the face,
oral cavity, and digits. Dysmorphic features affecting the
head include facial asymmetry, hypertelorism, micro-
gnathia, broadened nasal ridge, and facial milia. Oral
cavity lesions reported for this syndrome are median
pseudoclefting of the upper lip (45%), clefts of the palate
(180%) and tongue (30%), and oral frenulae. Thickened
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alveolar ridges and abnormal dentition, including absent
lateral incisors, are additional characteristics of OFD1.
The digital abnormalities, which affect the hands
(50%–70%) more often than the feet (25%), include
syndactyly, brachydactyly, clinodactyly, and, more
rarely, pre- or postaxial polydactyly. The CNS may also
be involved in as many as 40% of cases. Involvement
of the CNS includes mental retardation, hydrocephalus,
cerebellar anomalies, porencephaly, and agenesis of the
corpus callosum (Towfighi et al. 1985; Connacher et al.
1987). In recent years, with the introduction of high-
resolution renal ultrasound scanning, it has become ev-
ident that polycystic kidney disease is commonly asso-
ciated with OFD1 (Connacher et al. 1987; Donnai et al.
1987; Scolari et al. 1997), with reports of patients in
whom the renal involvement completely dominates the
clinical course of the disease (Coll et al. 1997; Feather
et al. 1997a).
These clinical features overlap with those reported in
the other nine forms of OFDS (Toriello 1993), although
among these, OFD1 can be easily distinguished, because
of its X-linked dominant inheritance pattern and be-
cause of the polycystic kidney disease, which seems to
be specific to type 1. The locus of OFD1 was first
mapped by linkage analysis to a 19.8-cM interval,
flanked by crossovers with markers DXS996 and
DXS7105 in the Xp22 region (Feather et al. 1997b).
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More recently, the interval was narrowed by Gedeon et
al., to a 12-Mb interval of the same region (1999).
Patients, Material, and Methods
Patients
We screened, by direct sequencing, genomic DNA
from three familial and four sporadic cases. Although
there is overlap with other oral-facial-digital syndromes,
the phenotype of OFD1 is highly specific (Toriello 1993),
and all patients included in this study were diagnosed
with OFD1. In particular, the familial cases were selected
on the basis of the X-linked inheritance and/or because
of the presence of polycystic kidneys. A summary of the
clinical features is given in table 1. An example of the
digit anomalies and an ultrasound scan displaying the
polycystic lesions reported for this syndrome are pro-
vided in figure 1.
Mutation Analysis
Primers and conditions used for mutation analysis are
available at the TIGEM website. PCRs were performed,
by means of the Gentra systems Capture Column Kit,
on genomic DNA extracted from peripheral blood leu-
kocytes. Using the ABI Prism Big Dye Terminator Cycle
Sequencing Kit (PE Biosystems) and an ABI 377 auto-
mated DNA sequencer, we checked PCR products on
agarose gel and then sequenced them on both strands.
When necessary, PCR amplification products were
cloned, by means of the TOPO TA cloning kit supplied
by Invitrogen, to separate the mutant and wild-type al-
leles. Ninety normal X chromosomes from white indi-
viduals were analyzed by SSCP for exons 3, 11, and 13,
as described (Orita et al. 1989), whereas the same num-
ber of chromosomes were analyzed for exon 16 by de-
naturing high-performance liquid chromatography, us-
ing the Wave DNA fragment analysis system (Trans-
genomic, Inc.), according to the manufacturer’s instruc-
tions. Mutation description follows standard nomencla-
ture (Antonarakis 1998). All the patients and controls
used in this study were white, and ethical approval was
obtained by the universities and research institutes in-
volved in this study.
In Situ Hybridization Studies
RNA in situ studies were performed on mouse tissue
sections at E10.5, E12.5, E14.5, and E16.5, by means
of radioactive in situ hybridization, according to pub-
lished protocols (Rugarli et al. 1993). The sense strand
of the same fragment did not reveal any detectable signal
above the background level (data not shown).
Results
A systematic mutation analysis of genes located in Xp22
in seven female patients with OFD1 was done. Six can-
didate genes (MSL3L1, MAEG, RAB 9, STK9, M1D1,
and pirin) were selected on the basis of their known
functions and/or expression patterns and were excluded
by mutation analysis (B. Franco, unpublished data; Prak-
ash et al. 1999; Buchner et al. 2000). We then decided
to analyze Cxorf5 (alias 71-7a) (GenBank accession
numbers Y15164 and Y16355), one of the first tran-
scripts to be assigned to the X chromosome (Kunkel et
al. 1983) and included in the OFD1 critical region (de
Conciliis et al. 1998). Characterization of the cDNA
clones revealed the existence of two alternative tran-
scripts—namely, Cxorf5-1 and Cxorf5-2, which are dif-
ferentiated by the use of an alternative 3′ splice site. The
Cxorf5-1 transcript is predicted to encode a 1011–amino
acid protein with a molecular mass of 116 kDA, whereas
Cxorf5-2 encodes a predicted protein of 367 amino ac-
ids, containing the first 351 residues of the Cxorf5-1
protein and an alternative C-terminal region of 16 amino
acids (de Conciliis et al. 1998). Searches of nonredun-
dant DNA and databases with the BLAST algorithm,
using both the Cxorf5-1 and the Cxorf5-2, predicted
proteins; queries did not reveal significant homology
with previously characterized genes and proteins except
for the presence of coiled-coil domains (data not shown;
de Conciliis et al. 1998). Using genomic sequences avail-
able in public databases (GenBank accession number
AC003037), we designed primers for PCR amplification
of all 23 coding exons, including splice junctions.Cxorf5
was reported to have related loci on both Yq11.22
(Cyorf1) and 5p13 (C5orf1) regions (de Conciliis et al.
1998). Cyorf1 represents a pseudogene (de Conciliis et
al. 1998). Concerning C5orf1, Blastn searches of the htgs
and gss databases, using the Cxorf5 sequence as query,
reveals a genomic sequence corresponding to the C5orf1
locus (AC025449). This sequence is colinear with most
of the coding region of the Cxorf5 transcript and does
not contain introns (data not shown). On the basis of
these results, primers were designed in order to specifi-
cally amplify the X chromosome transcript.
Mutation Studies
The patients included in this study were analyzed for
the 23 coding exons of the Cxorf5 gene. Mutations were
identified in all the patients, and a summary of the results
is reported in table 2. Among the familial cases, we iden-
tified a missense mutation and two intragenic deletions.
In family 1, a 1303 ArC transversion, which changed
a polar amino acid (serine) to a basic amino acid (ar-
ginine) at codon 434 (S434R), was identified (table 2).
Table 1
Clinical Features of Patients with OFD1 Who Were Included in the Study
FAMILY
(CASEa)
ANOMALIES
Oral Facialb Hand/Foot Cerebral Kidney Miscellaneousb
1 (F) Hamartomas, dental anomalies, cleft
tongue, highly arched palate
Skin milia, dolichocephaly, down-
slanting palpebral fissures
… Suprasellar expansive lesion, mild
mental retardation
… Alopecia, coarse hair
3 (F) Cleft palate, frenula, lingual hamartomas Alar hypoplasia Polydactyly, short second right toe Cysts of cerebral hemisphere Polycystic …
4 (F) Cleft palate/upper lip Facial asymmetry Clinodactyly, syndactyly Moderate mental retardation, mild
cerebral atrophy
Polycystic Alopecia, dry hair, liver/pancreatic
cysts
6 (S) Frenula, cleft gums, lingual hamartomas Skin milia Syndactyly … … …
10 (S) Cleft lip/palate NA Syndactyly … … NA
27 (S) Cleft palate, dental anomalies, tongue-tied Skin milia … Learning difficulties Polycystic …
28 (S) Cleft palate/upper lip, dental anomalies Skin milia Brachydactyly, clinodactyly Learning difficulties … Patchy alopecia
a F p familial; S p sporadic.
b NA p not available.
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Figure 1 A and B, Upper- and lower-digit abnormalities in a 12-year-old girl with OFD1. Note brachydactyly and syndactyly.C,Ultrasound
scan of kidney of the same individual who is depicted in A and B. She had chronic renal excretory failure and polycystic kidneys: note the
cysts (white arrows), up to 1 cm in diameter, located in the parenchyma of the organ.
Table 2
Mutations in Patients with OFD1
Family
(Casea) Location Nucleotide Changeb Effect on Protein
1 (F) Exon 13 1303ArC S434R
3 (F) Exon 3 312delG Frameshift
4 (F) Exon 3 294–312delTGGTTTGGCAAAAGAAAAG Frameshift
6 (S) Exon 3 121CrT Nonsense mutation
10 (S) Exon 11 1071–1078 del GAAGGATG / 1071–1078 ins TTTTTCCT KDD 357–359del/FSY 357–359ins
27 (S) Intron 4 3122del (6) Abnormal splicing
28 (S) Exon 16 1757delG Frameshift
a F p familial; S p sporadic.
b Mutation description is according to standard nomenclature, with the cDNA sequence ofOFD1 used as the reference
and with the ATG translation-initiation codon numbered as 1.
DNA from the affected mother and grandmother was
analyzed, and the same mutation was recognized, al-
though the father’s DNA displayed a normal pattern
(data not shown). In family 3 (Odent et al. 1998), a
deletion of a G at nucleotide 312, leading to a frameshift,
was identified (table 2). This deletion was confirmed
after cloning and analysis of the two distinct alleles. The
same mutation was also identified in DNA extracted
from an affected female fetus aborted after a 5-wk-old
pregnancy from the family described elsewhere (data not
shown).
Sequence analysis of family 4 (Scolari et al. 1997)
revealed an abnormal pattern, and the study of the two
separate alleles identified a deletion of 19 bp in exon 3,
leading to a frameshift (fig. 2). This family was studied
by SSCP, and although the same abnormal shift was
observed in the affected daughter and mother, the father
and the unaffected son and daughter displayed a normal
pattern. These results were confirmed by sequence anal-
ysis and demonstrate that, in this family, the mutation
segregates with the disease.
Among the sporadic cases, we identified one missense,
one nonsense, one splice, and one frameshift mutation
(table 2). In family 6, a 121 CrT transition creates a
termination codon TGA (R41X) in exon 3. DNA sam-
ples from this patient’s parents were not available for
molecular studies. In family 10, a deletion of eight bases,
followed by an insertion of eight bases, causes the sub-
stitution of three amino acids: basic, acid, and acid
(KDD), respectively, with another three amino acids: hy-
drophobic, polar, and polar (FSY) (fig. 3). We analyzed
DNA samples from both parents by direct sequencing,
and no abnormalities were found, which demonstrates
that this is a de novo mutation. In family 27, a 312
deletion of six bases (taaagt) was identified,2 312
, and similar mutations have been shown to dis-2del(6)
rupt splicing. A deletion of a G at base 1757, resulting
in a frameshift, was identified in family 28 (table 2). For
both of these latter mutations, maternal DNA was an-
alyzed and revealed a normal pattern; the father’s DNA
was not available for the study. Thus, since OFD1 is an
X-linked dominant male lethal condition, these can be
considered de novo mutations. None of the mutations
found in patients with OFD1 were identified in 90 nor-
mal X chromosomes, which were analyzed for exons 3,
11, 13, and 16.
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Figure 2 Analysis of family 4. Left panel, Sequencing chromatograms showing the genomic sequence of the affected individual (P) and
of wild-type (W) and mutant (M) alleles. Note the presence of double peaks in the patient’s DNA, downstream of the deletion due to the
presence of both normal and out-of-frame alleles. In the wild-type allele, the 19-bp deletion is indicated by a horizontal bracket. Single alleles
have been separated by cloning the PCR products. Right panel, Segregation of the 19-nucleotide deletion with the disease phenotype in family
4. After visualization of the PCR products on a 4% agarose gel, two different bands, corresponding to the wild-type (316-bp) and the mutant
(297-bp) alleles, appear in the affected individuals (lanes 1 and 2), whereas only the wild-type band is visible in the unaffected individuals (lanes
3–5). In the next-to-last lane, a normal female control is depicted. In the last lane, the PCR-negative control (no DNA) is reported. The lozenge
in the genealogical tree indicates an aborted fetus of unknown sex.
Expression Studies
Studies have shown that OFD1 is expressed in all adult
tissues examined (pancreas, kidney, skeletalmuscle, liver,
lung, placenta, brain, and heart) (de Conciliis et al.
1998). To investigate the spatiotemporal expression
of this transcript during development, a partial mur-
ine cDNA expressed-sequence tag (IMAGE 656917 was
identified by BLAST analysis from the Expressed Se-
quence Tags database, was entirely sequenced, and was
used for RNA in situ studies on mouse-embryo tissue
sections at different developmental stages. The first site
of expression was sharply and exclusively detected at
12.5 days of gestation in the genital ridges.
At later stages (E14.5 and E16.5), Ofd1 expression is
not only confined in the developing gonads, but high-
to-moderate levels of expression are detected in various
craniofacial structures and in the nervous system. In par-
ticular,Ofd1 is highly expressed in the epithelium lining
the oral and nasal cavities, including the tongue and the
gum region, in the developing tooth buds, in the
Rathke’s pouch (primordium of the adenohypophysis),
and in the vibrissae follicles (fig. 4a–f). The transcript is
also highly represented in the following structures: the
proliferative and postmitotic layers of the cerebral cortex
and ganglionic eminences (anlage of the basal ganglia),
the neural retina, the inner ear, and the dorsal root gan-
glia. Postnatally, the expression in the CNS is diffuse to
all the structures but has a higher level in the hippo-
campus and cerebellum (fig. 4g). Other organs express-
ing Ofd1 at a lower level are the integumentary system,
the lung, the thymus, and the kidney (fig. 4 and data
not shown).
Discussion
On the basis of the results presented in this paper, we
conclude that mutations in Cxorf5 are the cause of
OFD1 in the patients we analyzed, and we thus named
the transcriptOFD1 (Human Gene Nomenclature Com-
mittee–approved gene symbol and gene name. Most (6/
8) of the mutations identified so far lead to a premature
truncation of the protein in its N-terminal region and
are therefore predicted to act with a loss of function
mechanism. However, due to interference with wild-type
proteins in females, we cannot rule out the possibility
that truncated OFD1 proteins act with a dominant-neg-
ative effect.
OFD1 is the first gene for an X-linked dominant male
lethal disorder found to escape X inactivation (de Con-
ciliis et al. 1998). Apparently, in affected females, one
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Figure 3 Mutation of OFD1 in family 10. The DNA-sequence
fluorogram of the patient’s DNA for exon 11 displays eight double
peaks that result from the presence of both the wild-type and the
mutant alleles (top). After the PCR product was cloned, the wild-type
allele (bottom) and themutant allele (middle) were analyzed separately.
The corresponding amino acid sequence is shown above the nucleotide
sequence; the interchange of nine nucleotides results in a change of
the three amino acids shown in boldface type.
normal copy is not sufficient to protect from the dis-
order. It is conceivable to hypothesize that normal males
who carry only one normal copy ofOFD1 may display
a higher expression of the transcript on the single active
X chromosome, but further studies are needed to com-
pare, from a quantitative point of view, the level of
expression of this transcript in both sexes. A similar
mechanism has been reported for the Clc4 gene, which
is X linked and subject to X inactivation in Mus spretus
but autosomal in laboratory strains of mice (Rugarli et
al. 1995). Quantitative analysis demonstrated that,
compared with the single active X-linked locus, each
autosomal locus has half the level of Clc4 expression
(Adler et al. 1997). An alternative hypothesis is that
OFD1 undergoes X inactivation in the tissues affected
in OFD1 syndrome at developmental stages when its
function is necessary. Therefore, some tissues of affected
females at certain stages during development may result
in OFD1 functional nullisomy, by inactivation of the
normal X. Individual variation in the X-inactivation
pattern of this gene may also explain the clinical vari-
ability observed in OFD1 syndrome. More detailed X-
inactivation studies are needed to test this hypothesis.
Prior study had shown that OFD1 is ubiquitously
expressed in adult tissues. Since the clinical features ob-
served in this syndrome are suggestive of a develop-
mental disorder, we decided to study the expression pat-
tern of the Ofd1 gene during development in mouse-
embryo tissue sections.
Our studies showed a high-to-moderate level of ex-
pression in various craniofacial structures and in the
nervous system, and lower levels of expressionwere also
detected in the integumentary system, the lung, the thy-
mus, and the kidney. These sites of expression correlate
well with the tissues affected in patients with OFD1.
OFD1 is characterized by craniofacial anomalies,
such as facial skin milia, alar hypoplasia (broadened
nasal ridge), and facial asymmetry; oral anomalies in-
clude hamartomas, clefts of lip and palate, and dental
abnormalities. Consistently, expression of Ofd1 is de-
tected in the olfactory and respiratory epithelium of the
nasal cavities and nasopharynx, in several ectodermally
derived structures of the mouth and palate (upper lips,
the surface epithelium of the gum region of the mouth,
and tooth primordia), and in the endoderm-derived sur-
face epithelium of the tongue and oropharynx (fig.
4a–f). OFD1 is also characterized by an involvement of
the CNS in as many as 40% of the cases with reports
of mental retardation, seizures, and other neurological
defects (Towfighi et al. 1985; Connacher et al. 1987).
In the embryonic nervous system (E14.5 and E16.5),
Ofd1 expression is specifically detected in telencephalic
primordia of the cerebral cortex and striatum, as well
as in cranial and dorsal root ganglia (fig. 4a–f). In post-
natal brain (P12.5), Ofd1 transcript is detected in all
structures, although with a specifically higher expres-
sion in the hippocampal region (fig. 4f). Ofd1 is also
expressed at lower levels in the lung, the thymus, the
integumentary system (surface ectoderm and vibrissae
follicles) and the kidney, which can be related to the
alopecia and hair problems and with the kidney ab-
normalities reported for this syndrome (fig. 4a–f and
data not shown).
Since OFD1 shares no sequence homologies—apart
from the presence of coiled-coil domains—with other
proteins having known functions either in mammals or
in lower organisms, it is difficult at this point to predict
its function. The presence of several coiled-coil domains
suggests that OFD1 acts via a protein-protein interac-
tion mechanism. Identification of OFD1 protein inter-
actors may lead to the discovery of novel genes involved
in mammalian development and possibly implicated in
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Figure 4 Expression analysis of Ofd1, revealed by in situ hybridization
other types of OFD syndromes. Furthermore, since
OFD1 is often associated with polycystic kidney, it is
intriguing to note that PKD1 and PKD2, the genes re-
sponsible for autosomal dominant polycystic kidney
disease, physically interact through a coiled-coil domain
(Qian et al. 1997).
The mouse mutant with X-linked dominant polydac-
tyly (Xpl) maps to the region of the mouse X chro-
mosome, where the murine counterpart of Ofd1 has
been localized (Sweet and Lane 1980; de Conciliis et al.
1998). This mutant is characterized by urogenital mal-
formations (hydroureter, hydronephrosis, and cystic or
absent kidneys) and polydactyly (Sweet and Lane 1980),
and may be considered the possible mouse model of
OFD1. We are currently testing whether mutations in
Ofd1 may be responsible for the Xpl phenotype. If this
is the case, the availability of a mouse model will allow
functional studies toward the understanding of the path-
ogenesis of this syndrome.
In conclusion, the identification of the first gene in-
volved in OFDS will be instrumental in the elucidation
of the molecular mechanisms underlying this complex
group of developmental disorders and may shed new
light on the pathogenesis of polycystic kidney disease.
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